COMMUNIQUÉS West-GlobeNewswire

Extendicare Announces Timing of 2019 First Quarter Results and Conference Call
29/04/2019
MARKHAM, Ontario, April 29, 2019 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2019, after [...]
LogicBio Therapeutics Receives FDA Orphan Drug Designation for LB-001 for the Treatment of Methylmalonic Acidemia
29/04/2019
CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- LogicBio Therapeutics, Inc. (NASDAQ:LOGC), a genome editing company focused on developing medicines to durably treat rare diseases in pediatric patients, today [...]
Medovex Corporation Announces Recent Management Appointments
29/04/2019
Highly Experienced Team Responsible for Building a Previous $250M Plus Revenue Health Care Enterprise Reunited Under CEO Bill Horne ALPHARETTA, Ga., April 29, 2019 (GLOBE NEWSWIRE) -- Medovex Corporation (OTCQB: MDVX [...]
ChemioCare Announces Appointment of Roy F. Waldron to Its Board of Directors
29/04/2019
NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- ChemioCare USA Inc. (“ChemioCare” or the “Company”), a platform company focused on proprietary transdermal delivery, announced today the appointment of Roy F. Waldron to its [...]
Aleafia Health Reports 2018 Fiscal Year-end Results, Provides Corporate Update
29/04/2019
Aleafia & Emblem Y/Y Pro-forma Revenue Increases 327% to $11.5M Buildout of Three Production Facilities Nearing Completion Anticipated Annual Cannabis Cultivation & Extraction Capacity to Reach 138,000 kg, 50, [...]
Immunomedics and Everest Medicines Announce Exclusive License Agreement for Sacituzumab Govitecan in East and Southeast Asia Excluding Japan
29/04/2019
The Largest Single-Asset License Agreement for Greater China To Date Provides Everest Medicines the Right to Develop and Commercialize Sacituzumab Govitecan for All Cancer Indications in Greater China, South Korea, and [...]
Immunomedics Announces Departure of Chief Medical Officer
29/04/2019
MORRIS PLAINS, N.J., April 29, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Dova Pharmaceuticals Receives Positive Opinion from CHMP for DOPTELET® (avatrombopag) for the Treatment of Thrombocytopenia in Patients with Chronic Liver Disease
29/04/2019
Positive Opinion based on positive efficacy and safety data from two Phase 3 clinical trials DURHAM, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) today announced the Committee for [...]
Multiple Myeloma Research Foundation (MMRF) Venture Philanthropy Fund Invests in NexImmune to Advance Novel Immunotherapy Candidate Into Clinical Trials
29/04/2019
Partnership yields the first investment from newly launched MMRF Myeloma Investment Fund GAITHERSBURG, Md. and NORWALK, Conn., April 29, 2019 (GLOBE NEWSWIRE) -- NexImmune and the Multiple Myeloma Research Foundation ( [...]
Intellia Therapeutics Presents New In Vivo and Engineered Cell Therapy Data at the 22nd Annual Meeting of the American Society of Gene and Cell Therapy
29/04/2019
Intellia scientists advance CRISPR-mediated targeted gene insertion in non-human primates Achieved normal circulating human Factor IX protein levels in non-human primates using targeted gene insertion High rate and [...]
The Hawkesbury and District General Hospital Licenses TREAT as Part of the Regionalized Expansion of the TREAT EHR Through Ottawa Hospital
29/04/2019
TORONTO, April 29, 2019 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company”) (TSXV: VHI) is pleased to announce the licensing of the TREAT EHR to the Hawkesbury and District General Hospital (HGH). The Hawkesbury and [...]
Block Listing Interim Review
29/04/2019
BLOCK LISTING SIX MONTHLY RETURN (Note: Italicised terms have the same meaning as given in the Listing Rules.) Date: 29 April 2019 Name of applicant : Summit Therapeutics plc Name of scheme: 2005 EMI Scheme Period of [...]
Biogen Announces Three New Nominees for Election to Board of Directors
29/04/2019
Nominees Bring Decades of Management and Global Operating Experience, Including at Leading Healthcare Companies CAMBRIDGE, Mass., April 29, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) today announced the nomination [...]
Voyager Therapeutics Announces New Data in Multiple Presentations at the American Society of Gene and Cell Therapy 2019 Annual Meeting
29/04/2019
Voyager’s vectorized antibody program directed against tau demonstrates antibody distribution and expression levels in specific cell types that further facilitate studies with a vectorized antibody in animal models of [...]
Axsome Therapeutics To Report First Quarter 2019 Financial Results On May 9, 2019
29/04/2019
Axsome to host conference call and webcast on Thursday, May 9, 2019 at 8:00 AM Eastern Time NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical [...]
Share buy-back week 17/2019
29/04/2019
Announcement 29 April 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling [...]
ASLAN Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Corporate Update
29/04/2019
SINGAPORE, April 29, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical stage oncology and immunology focused biopharmaceutical company developing novel therapeutics for global markets, [...]
ViroGates Releases First Quarter 2019 Results
29/04/2019
Company announcement no. 8-2019 Birkerød, 29 April 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO), who delivers blood test systems for emergency departments in hospitals, today reported financial results for the [...]
Revised Financial Calendar 2019
29/04/2019
Company announcement no. 7-2019 Birkerød, 29 April 2019 ViroGates A/S (Nasdaq First North Denmark: VIRO) has revised its financial calendar for 2019: 20 March Deadline for submission of business to be transacted at the [...]

Pages